Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Switching to sirolimus in renal transplant recipients with hepatitis C virus: a safe option.

Transplantation proceedings - 1 Jan 2000

Gallego R, Henriquez F, Oliva E, Camacho R, Hernández R, Hortal L, Sablón N, Quintana B, Santana R, Gonzalez F, Palop L, Vega N

Abstract excerpt

INTRODUCTION: The presence of hepatitis C virus (HCV) in renal transplant recipients is an independent risk factor for death and graft failure. Chronic allograft nephropathy (CAN) favored by the use of calcineurin inhibitors (CNI) is one of the main causes of graft loss, whereas sirolimus (SRL) has proven to maintain better graft function with lower rates of CAN. OBJECTIVES AND METHODS: We developed a protocol to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adrenal Cortex Hormones
Share to Cyclosporine

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Erythropoietin

Share to Hepatitis C

Share to Immunosuppressive Agents

Share to Kidney Transplantation

Share to Safety

Share to Sirolimus

Source

Identifiers

PMID: 19715912
DOI: 10.1016/j.transproceed.2009.06.064

Genes

SRL

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Switching to sirolimus in renal transplant recipients with hepatitis C virus: a safe option.PMID 19715912Read ↗

Management of hepatitis B after renal transplantation: an update.Semantic proximity Read ↗

Rationale and criteria of eligibility for calcineurin inhibitor interruption following kidney transplantation.Semantic proximity Read ↗

Resistant Cytomegalovirus Infection After Renal Transplantation: Literature Review.Semantic proximity Read ↗

Does cyclosporine have a beneficial effect on the course of chronic hepatitis C infection after renal transplantation?Semantic proximity Read ↗

Profiling sirolimus-induced inflammatory syndrome: a prospective tricentric observational study.Semantic proximity Read ↗

Hepatitis C virus genotypes and the influence of the induction of immunosuppression with anti-thymocyte globulin (ATG) on chronic hepatitis in renal graft recipients.Semantic proximity Read ↗

Cellular immune response and cytokine profile among hepatitis C positive living donor renal transplant recipients.Semantic proximity Read ↗

Effects of immunosuppressants on the progression of hepatitis C in hepatitis C virus-positive renal transplantation and the usefulness of interferon therapy.Semantic proximity Read ↗

The burden of anti-HCV genotye-4 positivity in renal transplant recipients: 8 years follow-up.Semantic proximity Read ↗

Conversion to sirolimus in kidney transplant recipients with squamous cell cancer and changes in immune phenotype.Semantic proximity Read ↗

A delicate balance between rejection and BK polyomavirus associated nephropathy; A retrospective cohort study in renal transplant recipients.Semantic proximity Read ↗

Long-term ribavirin therapy in hepatitis C virus-positive renal transplant patients: effects on renal function and liver histology.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.